Summary & Overview
HCPCS C1604: Implantable Transmural Transvenous Arterial Bypass Graft
HCPCS Level II code C1604 designates an implantable graft for a transmural transvenous arterial bypass supplied with all delivery system components. Such implantable vascular devices are critical in complex vascular and cardiothoracic procedures where reestablishing arterial flow via a transvenous route is required. Nationally, these devices influence surgical planning, device procurement, and billing classification for high-acuity vascular interventions.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical sites of service, payer coverage landscape, common modifiers seen with device and procedure billing, and related coding considerations. The publication covers benchmarks and policy considerations relevant to hospital and inpatient billing for implantable vascular grafts, highlights areas where coverage variation commonly appears, and summarizes coding guidance tied to device supply and delivery components. This summary is intended for revenue integrity, clinical coding, and supply chain stakeholders who manage high-cost implantable vascular devices and need a clear, national-level synopsis of HCPCS Level II code C1604.
Billing Code Overview
HCPCS Level II code C1604 represents an implantable graft device for transmural transvenous arterial bypass, supplied with all delivery system components. This device is used to create an arterial bypass via a transvenous approach for transmural graft placement.
-
Service type: Implantable vascular graft with delivery system components
-
Typical site of service: Hospital operating room or inpatient surgical setting for vascular or cardiothoracic procedures
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with severe peripheral arterial disease or complex venous-arterial access needs who requires a transmural transvenous arterial bypass graft implantable device (C1604) to restore arterial perfusion. The patient often presents with chronic limb-threatening ischemia, rest pain, non-healing ischemic ulceration, or recurrent graft failure after prior reconstructive attempts. Preoperative evaluation includes vascular imaging (duplex ultrasound, CTA or MRA, and diagnostic angiography), cardiopulmonary assessment, medication optimization (antiplatelet and/or anticoagulation management), and wound care consultation if tissue loss is present.
The clinical workflow: the patient is brought to a hybrid operating room or interventional radiology suite. Under general or monitored anesthesia care, vascular access is obtained percutaneously or via open exposure. The transmural transvenous arterial bypass graft and delivery system (C1604) are implanted using fluoroscopic and endovascular techniques, often with adjunctive angioplasty or stenting. Intraoperative angiography confirms graft position and flow. Postprocedure care includes vascular monitoring, limb perfusion checks, anticoagulation management, wound care, and surveillance imaging at planned intervals. Typical sites of service are an inpatient operating room, ambulatory surgery center, or an interventional radiology suite within a hospital setting depending on patient acuity and facility capabilities.
Coding Specifications
| Modifier | Description | When to Use |
|---|